|
|
Blood, Vol. 111, Issue 4, 1840-1847, February 15, 2008
Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria
Blood Brodsky et al.
111: 1840
Supplemental materials for: Brodsky et al
In addition to the authors, the following investigators and institutions participated in the clinical studies: Australia — Princess Alexandra Hospital, Woolloongabba: A. Mills
Queen Elizabeth Hospital, Woodville South: J. Norman
Royal Melbourne Hospital, Parkville: J Szer
Royal Perth Hospital, Perth, WA: R. Herrmann
Royal North Shore Hospital, St Leonards: A. Chris, J. Curnow Belgium — St. Luc University Hospital, UCL, Brussels: E. Van Den Neste, A. Ferrant Canada — London Health Sciences Centre, London, Ontario: I. Chin-Yee Germany — Universitätsklinikum Essen, Essen: U Dührsen, A Röth
Medizinische Hochschule Hannover, Hannover: A. Ganser
Institut für Klinische Transfusionsmedizin and Immungenetik, University Hospital Ulm, Ulm: S Koerper, B Höchsmann
Saarland University Medical School, Hamburg Ireland — St. James Hospital, Dublin: P. Browne Italy — Ospedale San Martino, Genoa: A. Bacigalupo
Azienda Policlinico Umberto I - Univ. La Sapienza, Rome: R. Foà, A. Iori, F. Milano, G. Torelli
Azienda-Ospedaliera Universitaria Careggi, Florence: G. Gianfaldoni, F. Mannelli, A. Bosi
Ospedale San Bortolo, Vicenza: F. Rodeghiero
Federico II University, Naples: B. Rotoli, F. Alfinito
Ospedale Maggiore di Milano, Milan: A. Zanella, C. Boschetti
Istituto Toscana Tumori, Florence: L Luzzatto The Netherlands — Radboud University Medical Center, Nijmegen: P Muus Spain — Hospital De La Paz, Madrid: R. De Paz, M.A. Canales
Hospital Universitario Germans Trías I Pujol, Barcelona: J. Ribera, E. Orna
Hospital Clinic i Provincial, Barcelona: A. Urbano-Ispizua Sweden — Umea University Hospital, Umea: A. Wahlin
Stockholm South Hospital, Stockholm: J. Samuelsson, L.G. Lundberg, P. Andersson
University Hospital, Uppsala: M. Höglund Switzerland — Kantonsspital Basel, Basel: A. Tichelli, D. Heim, J. Passweg United Kingdom — St. George’s Hospital, London: M. Elebute
Leeds General Infirmary, Leeds: A Hill
Belfast City Hospital, Belfast: M.F. McMullin
Royal Cornwall Hospital, Cornwall: A. Kruger United States — Washington University School of Medicine, St. Louis, MO: L. Andritsos, M. Blinder, S. Devine
Johns Hopkins University Medical Center, Baltimore, MD
Stanford University Medical Center, Stanford, CA: S. Coutre
Norris Comprehensive Cancer Center Los Angeles, CA: I Weitz
Duke University Medical Center, Durham, NC
Cleveland Clinic Florida, Weston, FL: E. Stone
University of Pennsylvania, Philadelphia, PA: B. Konkle
Cleveland Clinic Foundation, Cleveland, OH: A. Lichtin
Mayo Clinic, Rochester, MN: R. Mesa
New York University Clinical Cancer Center, New York, NY: T. Moskovits, B.G. Raphael, E. Amorosi, K.B. Hymes, P. Cook
City of Hope National Medical Center, Duarte, CA: R. Nakamura
Indiana University Cancer Center, Indianapolis, IN: R. Nelson
Hartford Hospital, Hartford, CT: R. Siegel
National Heart, Lung, and Blood Institute, Bethesda, MD: B. Savani
University of Utah School of Medicine, Salt Lake City, UT: G. Meyers
|
|
